Views of US Voters on Compensating Living Kidney Donors | Nephrology | JAMA Surgery | JAMA Network
[Skip to Navigation]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 18.204.227.34. Please contact the publisher to request reinstatement.
1.
US Dept of Health and Human Services. Organ Procurement and Transplantation Network. http://optn.transplant.hrsa.gov/converge/latestData/viewDataReports.asp. Accessed September 24, 2015.
2.
Matas  AJ, Smith  JM, Skeans  MA,  et al.  OPTN/SRTR 2012 annual data report: kidney.  Am J Transplant. 2014;14(suppl 1):11-44.PubMedGoogle ScholarCrossref
3.
Segev  DL, Muzaale  AD, Caffo  BS,  et al.  Perioperative mortality and long-term survival following live kidney donation.  JAMA. 2010;303(10):959-966.PubMedGoogle ScholarCrossref
4.
Lam  NN, Lentine  KL, Levey  AS, Kasiske  BL, Garg  AX.  Long-term medical risks to the living kidney donor.  Nat Rev Nephrol. 2015;11(7):411-419.PubMedGoogle ScholarCrossref
5.
Gentry  SE, Montgomery  RA, Segev  DL.  Kidney paired donation: fundamentals, limitations, and expansions.  Am J Kidney Dis. 2011;57(1):144-151.PubMedGoogle ScholarCrossref
6.
Jendrisak  MD, Hong  B, Shenoy  S,  et al.  Altruistic living donors: evaluation for nondirected kidney or liver donation.  Am J Transplant. 2006;6(1):115-120.PubMedGoogle ScholarCrossref
7.
Chatterjee  P, Venkataramani  AS, Vijayan  A, Wellen  JR, Martin  EG.  The effect of state policies on organ donation and transplantation in the United States.  JAMA Intern Med. 2015;175(8):1323-1329.PubMedGoogle ScholarCrossref
8.
National Organ Transplantation Act, 42 USC §273-274 (1984).
9.
Klarenbach  S, Gill  JS, Knoll  G,  et al; Donor Nephrectomy Outcomes Research (DONOR) Network.  Economic consequences incurred by living kidney donors: a Canadian multi-center prospective study.  Am J Transplant. 2014;14(4):916-922.PubMedGoogle ScholarCrossref
10.
Warren  PH, Gifford  KA, Hong  BA, Merion  RM, Ojo  AO.  Development of the National Living Donor Assistance Center: reducing financial disincentives to living organ donation.  Prog Transplant. 2014;24(1):76-81.PubMedGoogle ScholarCrossref
11.
 Patient assistance program. American Transplant Foundation. http://www.americantransplantfoundation.org/programs/pap/. Accessed May 6, 2015.
12.
Fisher  JS, Butt  Z, Friedewald  J,  et al.  Between Scylla and Charybdis: charting an ethical course for research into financial incentives for living kidney donation.  Am J Transplant. 2015;15(5):1180-1186.PubMedGoogle ScholarCrossref
13.
Matas  AJ, Satel  S, Munn  S,  et al; Working Group on Incentives for Living Donation.  Incentives for organ donation: proposed standards for an internationally acceptable system.  Am J Transplant. 2012;12(2):306-312.PubMedGoogle ScholarCrossref
14.
Rippon  S.  Imposing options on people in poverty: the harm of a live donor organ market.  J Med Ethics. 2014;40(3):145-150.PubMedGoogle ScholarCrossref
15.
Danovitch  G.  Cash, rewards, and benefits in organ transplantation: an open letter to Senator Arlen Specter.  Curr Opin Organ Transplant. 2009;14(2):129-133.PubMedGoogle ScholarCrossref
16.
Kahn  JP, Delmonico  FL.  The consequences of public policy to buy and sell organs for transplantation.  Am J Transplant. 2004;4(2):178-180.PubMedGoogle ScholarCrossref
17.
Peters  TG.  Life or death: the issue of payment in cadaveric organ donation.  JAMA. 1991;265(10):1302-1305.PubMedGoogle ScholarCrossref
18.
Salomon  DR, Langnas  AN, Reed  AI, Bloom  RD, Magee  JC, Gaston  RS; AST/ASTS Incentives Workshop Group (IWG).  AST/ASTS workshop on increasing organ donation in the United States: creating an “arc of change” from removing disincentives to testing incentives.  Am J Transplant. 2015;15(5):1173-1179.PubMedGoogle ScholarCrossref
19.
Delmonico  FL, Martin  D, Domínguez-Gil  B,  et al.  Living and deceased organ donation should be financially neutral acts.  Am J Transplant. 2015;15(5):1187-1191.PubMedGoogle ScholarCrossref
20.
United States Renal Data System.  2012 Annual Data Report: Epidemiology of Kidney Disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2012.
21.
Langnas  A, Salomon  DR.  Remove disincentives to organ donation. New York Times. August 21, 2014. http://www.nytimes.com/roomfordebate/2014/08/21/how-much-for-a-kidney/remove-disincentives-to-organ-donation. Accessed May 6, 2015.
22.
Rodrigue  JR, Kazley  AS, Mandelbrot  DA, Hays  R, LaPointe Rudow  D, Baliga  P.  Living donor kidney transplantation: overcoming disparities in live kidney donation in the US: recommendations from a consensus conference.  Clin J Am Soc Nephrol. 2015;10(9):1687-1695.PubMedGoogle ScholarCrossref
23.
McCarthy  J. Seven in 10 Americans back euthanasia. Gallup. June 18, 2014. http://www.gallup.com/poll/171704/seven-americans-back-euthanasia.aspx. Accessed November 18, 2014.
24.
Hoeyer  K, Schicktanz  S, Deleuran  I.  Public attitudes to financial incentive models for organs: a literature review suggests that it is time to shift the focus from ‘financial incentives’ to ‘reciprocity.’  Transpl Int. 2013;26(4):350-357.PubMedGoogle ScholarCrossref
25.
Barnieh  L, Klarenbach  S, Gill  JS, Caulfield  T, Manns  B.  Attitudes toward strategies to increase organ donation: views of the general public and health professionals.  Clin J Am Soc Nephrol. 2012;7(12):1956-1963.PubMedGoogle ScholarCrossref
26.
van Buren  MC, Massey  EK, Maasdam  L,  et al.  For love or money? attitudes toward financial incentives among actual living kidney donors.  Am J Transplant. 2010;10(11):2488-2492.PubMedGoogle ScholarCrossref
27.
Halpern  SD, Raz  A, Kohn  R, Rey  M, Asch  DA, Reese  P.  Regulated payments for living kidney donation: an empirical assessment of the ethical concerns.  Ann Intern Med. 2010;152(6):358-365.PubMedGoogle ScholarCrossref
28.
Gordon  EJ, Patel  CH, Sohn  MW, Hippen  B, Sherman  LA.  Does financial compensation for living kidney donation change willingness to donate?  Am J Transplant. 2015;15(1):265-273.PubMedGoogle ScholarCrossref
Original Investigation
August 2016

Views of US Voters on Compensating Living Kidney Donors

Author Affiliations
  • 1University of Florida College of Medicine, Jacksonville
  • 2FAIR Foundation, Palm Desert, California
  • 3Scripps Center for Organ Transplantation, La Jolla, California
  • 4Liver Transplant Program, Division of Gastroenterology and Hepatology, Department of Medicine, Stanford University Medical Center, Stanford, California
  • 5LifeQuest Organ Recovery Services, Gainesville, Florida
JAMA Surg. 2016;151(8):710-716. doi:10.1001/jamasurg.2016.0065
Abstract

Importance  Patients in the United States waiting for kidney transplantation die in increasing numbers owing to the severe kidney shortage, which might be alleviated by compensating living kidney donors.

Objective  To determine the willingness of voting US citizens to become living kidney donors and to ascertain the potential influence of compensation for donation.

Design, Setting, and Participants  A professionally designed quantitative survey was administered by an international polling firm in June 2014. Information was collected on willingness to donate a kidney and the potential influence of compensation ($50 000); survey data included respondent age, income, education level, sex, US region, race/ethnicity, marital status, political affiliation, likelihood to vote, and employment status. The survey was performed via a random-digit dialing process that selected respondents via both landlines and mobile telephones to improve population representation. The survey included 1011 registered US voters likely to vote.

Main Outcomes and Measures  The degree to which the US voting public is willing to donate a kidney and the perceptions of current voters toward paying living kidney donors.

Results  Of the 1011 respondents, 427 were male and 584 were female, with 43% of participants between ages 45 and 64 years. With respondents grouped by willingness to donate, we found that 689 (68%) would donate a kidney to anyone and 235 (23%) only to certain persons; 87 (9%) would not donate. Most (59%) indicated that payment of $50 000 would make them even more likely to donate a kidney, 32% were unmoved by compensation, and 9% were negatively influenced by payment.

Conclusions and Relevance  Most US voters view living kidney donation positively, and most would be motivated toward donor nephrectomy if offered a payment of $50 000. Because most registered voters favor such payments, and because thousands of lives might be saved should compensation increase the number of transplantable kidneys, laws and regulations prohibiting donor compensation should be modified to allow pilot studies of financial incentives for living kidney donors. Outcomes of such trials could then result in evidence-based policies, which would incorporate fair and just compensation to those persons willing to undergo donor nephrectomy.

×